Primary information |
---|
sequence ID | Seq_3025 |
Peptide sequence | GPPPPGKPQ |
CancerPDF_ID | CancerPDF_ID3864, CancerPDF_ID3865, CancerPDF_ID3881, CancerPDF_ID3882, CancerPDF_ID3903, CancerPDF_ID3904, CancerPDF_ID3941, |
PMID | 22809520,22809520,22809520,22809520,22809520,22809520,22809520 |
Protein Name | Basic PRP1 (Basic salivary proline-rich protein 1),Basic PRP1 (Basic salivary proline-rich protein 1),Basic PRP2 (Basic salivary proline-rich protein 2),Basic PRP2 (Basic salivary proline-rich protein 2),Basic PRP2 (Basic salivary proline-rich protein 2),Basic PRP2 (Basic salivary proline-rich protein 2),Basic PRP4 (Basic salivary proline-rich protein 4) |
UniprotKB Entry Name | PRP1_HUMAN,PRP1_HUMAN,PRPC_HUMAN,PRPC_HUMAN,PRPC_HUMAN,PRPC_HUMAN,A0A0A0MT31_HUMAN |
Fluid | Saliva,Saliva,Saliva,Saliva,Saliva,Saliva,Saliva |
M/Z | NA,NA,NA,NA,NA,NA,NA |
Charge | NA,NA,NA,NA,NA,NA,NA |
Mass (in Da) | NA,NA,NA,NA,NA,NA,NA |
fdr | 1482.89,1206.68,1206.68,1482.89,1206.68,1482.89,1206.68 |
Profiling Technique | LC-MS and iTRAQ,LC-MS and iTRAQ,LC-MS and iTRAQ,LC-MS and iTRAQ,LC-MS and iTRAQ,LC-MS and iTRAQ,LC-MS and iTRAQ |
Peptide Identification technique | MS/MS,MS/MS,MS/MS,MS/MS,MS/MS,MS/MS,MS/MS |
Quantification Technique | "2,4,6-trinitrobenzenesulfonic acid assay","2,4,6-trinitrobenzenesulfonic acid assay","2,4,6-trinitrobenzenesulfonic acid assay","2,4,6-trinitrobenzenesulfonic acid assay","2,4,6-trinitrobenzenesulfonic acid assay","2,4,6-trinitrobenzenesulfonic acid assay","2,4,6-trinitrobenzenesulfonic acid assay" |
Labelled/Label Free | Labelled,Labelled,Labelled,Labelled,Labelled,Labelled,Labelled |
FDR | NA,NA,NA,NA,NA,NA,NA |
CancerPDF_ID | CancerPDF_ID3864, CancerPDF_ID3865, CancerPDF_ID3881, CancerPDF_ID3882, CancerPDF_ID3903, CancerPDF_ID3904, CancerPDF_ID3941, |
p-Value | NA,NA,NA,NA,NA,NA,NA |
Software | MASCOT (v2.1.1),MASCOT (v2.1.1),MASCOT (v2.1.1),MASCOT (v2.1.1),MASCOT (v2.1.1),MASCOT (v2.1.1),MASCOT (v2.1.1) |
Length | 9,9,9,9,9,9,9 |
Cancer Type | Normal,Normal,Normal,Normal,Normal,Normal,Normal |
Database | SwissProt Database (release date 010111),SwissProt Database (release date 010111),SwissProt Database (release date 010111),SwissProt Database (release date 010111),SwissProt Database (release date 010111),SwissProt Database (release date 010111),SwissProt Database (release date 010111) |
Modification | iTRAQ8plex at N-term; iTRAQ8plex(K) at 7,iTRAQ8plex at N-term; iTRAQ8plex(K) at 7,iTRAQ8plex(K) at 9; Formyl at N-term;,iTRAQ8plex at N-term; iTRAQ8plex(K) at 7,NA,NA,FormylatN-term; iTRAQ8plex(K)at7 |
Number of Patients | NA,NA,NA,NA,NA,NA,NA |
Regulation | NA,NA,NA,NA,NA,NA,NA |
Validation | NA,NA,NA,NA,NA,NA,NA |
Sensitivity | NA,NA,NA,NA,NA,NA,NA |
Specificity | NA,NA,NA,NA,NA,NA,NA |
Accuracy | NA,NA,NA,NA,NA,NA,NA |
Peptide Atlas | NA |
IEDB | 505665
|